Haukeland University Hospital – Developmental Therapeutics Review – Q4 2010

Date: December 1, 2010
Pages: 24
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: H2150FD4145EN
Leaflet:

Download PDF Leaflet

Haukeland University Hospital – Developmental Therapeutics Review – Q4 2010
Haukeland University Hospital - Developmental Therapeutics Review - Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Haukeland University Hospital - Developmental Therapeutics Review - Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope
  • Review of therapeutics under development by Haukeland University Hospital.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Haukeland University Hospital with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of Haukeland University Hospital’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.

Reasons to buy
  • Review of therapeutics under development by Haukeland University Hospital.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Haukeland University Hospital with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of Haukeland University Hospital’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.
Haukeland University Hospital Snapshot
Key Facts
Haukeland University Hospital – Research and Development Overview
Key Therapeutic Areas
Haukeland University Hospital – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Haukeland University Hospital – Pipeline Products Glance
Haukeland University Hospital – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Haukeland University Hospital Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Haukeland University Hospital – Drug Profiles
Rituximab
Product Description
Mechanism of Action
R&D Progress
Bevacizumab
Product Description
Mechanism of Action
R&D Progress
Tetradecylthioacetic Acid
Product Description
Mechanism of Action
R&D Progress
Vaccine Vivotif + Vaccine Dukoral
Product Description
Mechanism of Action
R&D Progress
Haukeland University Hospital – Pipeline Analysis
Haukeland University Hospital – Pipeline Products by Therapeutic Class
Haukeland University Hospital Pipeline Products By Target
Haukeland University Hospital – Pipeline Products by Route of Administration
Haukeland University Hospital – Pipeline Products by Molecule Type
Haukeland University Hospital - Dormant Projects
Haukeland University Hospital – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 2

LIST OF TABLES

Haukeland University Hospital – Pipeline by Therapy Area and Indication, 2010
Haukeland University Hospital – Pipeline by Stage of Development, 2010
Haukeland University Hospital – Monotherapy Products in Pipeline, 2010
Haukeland University Hospital – Combination Treatment Modalities in Pipeline, 2010
Haukeland University Hospital – Phase III, 2010
Haukeland University Hospital - Phase II, 2010
Haukeland University Hospital - Pipeline By Therapeutic Class, 2010
Haukeland University Hospital - Pipeline By Target, 2010
Haukeland University Hospital – Pipeline By Route of Administration, 2010
Haukeland University Hospital – Pipeline By Molecule Type, 2010
Haukeland University Hospital - Dormant Developmental Projects, 2010 21

LIST OF FIGURES

Haukeland University Hospital – Pipeline by Therapy Area and Indication, 2010
Haukeland University Hospital – Pipeline by Stage of Development, 2010
Haukeland University Hospital – Monotherapy Products in Pipeline, 2010
Haukeland University Hospital – Combination Treatment Modalities in Pipeline, 2010
Haukeland University Hospital – Pipeline By Therapeutic Class, 2010
Haukeland University Hospital - Pipeline By Target, 2010
Haukeland University Hospital – Pipeline By Route of Administration, 2010
Haukeland University Hospital – Pipeline By Molecule Type, 2010 20

Ask Your Question

Haukeland University Hospital – Developmental Therapeutics Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: